Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Infrared Light Technology May Open New Opportunities to Image Cancer, Tay Sachs Disease

By LabMedica International staff writers
Posted on 28 Sep 2010
A technique employing near-infrared light enables scientists to look deeper into the workings of cells, potentially creating a new tool in the fight against cancer and many other diseases.

University of Central Florida (UCF; Orlando, USA) chemists, led by Prof. More...
Kevin Belfield, used near infrared light and fluorescent dye to take pictures of cells and tumors deep within tissue. The probes specifically target lysosomes, which have been linked to a variety of diseases, including types of mental illnesses and cancers.The probes can be adapted to look for specific proteins found in tumors, which means they someday may help physicians diagnose and potentially treat tumors. "This is a game-changer,” Prof. Belfield said. "Until now, there was no real way to study lysosomes because existing techniques have severe limitations. But the probe we developed is stable, which allows for longer periods of imaging.”

Conventional imaging probes work for only a few minutes. They cannot penetrate deep tissue, are sensitive to pH levels, and have poor water solubility. Prof. Belfield's technique jumps over those hurdles by using near-infrared light. Once researchers identified the correct light frequency, they took images of lysosomes for hours. The new approach will allow researchers to see lysosomes at work and to piece together their role in diseases such as cancer and Tay-Sachs, a genetic disorder from which children typically die by age four.

"We've come up with something that should make a huge difference in finding answers to some very complicated conditions,” Prof. Belfield concluded.

The study's findings, which include comparisons to the only two existing probes on the market today, were published in the August 2010 issue of the Journal of the American Chemical Society.

Related Links:

University of Central Florida




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.